[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 1, 2012

Radiation Therapy Modalities for Prostate Cancer

JAMA. 2012;308(5):450. doi:10.1001/jama.2012.8112

To the Editor: Dr Sheets and colleagues1 used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to retrospectively compare surrogate outcomes (claims) for patients with non–metastatic prostate cancer treated with 3 radiation modalities—conformal radiation therapy, IMRT, and proton therapy—advances expected to improve disease control and toxicity outcomes through improved radiation dose distribution.